Upgrade to SI Premium - Free Trial

Bernstein SocGen on Oracle (ORCL): 'Next catalyst is FAM'

September 11, 2026 9:36 AM
Bernstein SocGen Group analyst Mark Moerdler reiterated an Outperform rating and $325.00 price target on Oracle (NYSE: ORCL).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments